PulseSelect PFA heart ablation registry study
Part of Heart & circulation clinical trials.
This registry study collects information from people with atrial fibrillation (an irregular heartbeat) who are having a procedure using the PulseSelect PFA system. It helps doctors understand how well this treatment works in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old (or the minimum age in your area).
- You have been diagnosed with atrial fibrillation (a type of irregular heartbeat).
- Your doctor plans to use the PulseSelect PFA system (a special device for heart ablation).
- You agree to take part in the study and follow its rules.
- You are not currently in another study that hasn't been approved to join this one.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat atrial fibrillation (Afib) using a special catheter system called PulseSelect that delivers short bursts of energy to create scar tissue in the heart. It is for people whose Afib comes and goes or stays for a while but not more than a year, and who have not had a prior ablation procedure or have a pacemaker or defibrillator.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This trial is a registry that tracks patients who have had a second pulsed-field ablation (PFA) procedure for atrial fibrillation after a first PFA treatment. The goal is to learn more about how safe and effective these repeat procedures are.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.